Douglas Sacha/Getty Images(NEW YORK) — Opioid manufacturer Insys Therapeutics has agreed to pay a $225 million settlement to resolve the federal government’s criminal and civil investigations into the company’s illegal marketing of a powerful but highly-addictive painkiller, prosecutors said Wednesday. As part of the deal, Insys Therapeutics will pay a $2 million criminal fine and …
Jun 06
Opioid manufacturer Insys Therapuetics agrees to pay $225 million to settle criminal and civil investigations
